Smoking
793
49
71
588
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
187 trials with published results (24%)
Research Maturity
588 completed trials (74% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.4%
35 terminated out of 793 trials
94.4%
+7.9% vs benchmark
12%
95 trials in Phase 3/4
32%
187 of 588 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 588 completed trials
Clinical Trials (793)
Using Smartwatches to Monitor Smoking in Real-life Situations
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Functional Capacity, Subjective Dyspnea and Fatigue in Smokers
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Reduce Tobacco Use in People Living With HIV in Switzerland
A Patient-Oriented Research Mentoring Program in Tobacco Dependence and Implementation Science Research
BAPS in Botswana: The Thotloetso Trial
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
Abuse Liability of Two Modern Oral Nicotine Pouched Products
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
Salvation Army Tobacco Quit Line Referral Implementation Trial
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
Clinical Alternatives for Reducing Harm Using E-cigarettes
Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS